Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?

Andrew Chisom Madu1, Anthony David Dimarco1,2, Amy Hardy-Wallace1

  • 1Essex Cardiothoracic Centre, Basildon University Hospital, Basildon, UK.

Open Heart
|January 21, 2026
PubMed

Insights

A significant number of patients with inherited cardiomyopathy and a genetic cause did not meet UK testing criteria. Wider genetic testing (GT) guidelines, focusing on phenotype severity, could benefit at-risk relatives.

Area of Science:

  • Cardiovascular Genetics
  • Genomic Medicine

Background:

  • Inherited cardiac conditions like dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) often have a monogenic cause.
  • Genetic testing (GT) can identify pathogenic gene variants, impacting patient management and family screening.
  • Current UK National Genomic Test Directory (NGTD) criteria for GT are restrictive, contrasting with broader European Society of Cardiology (ESC) recommendations.

Purpose of the Study:

  • To determine the prevalence of pathogenic genotypes in patients with DCM or HCM who did not meet NGTD criteria for genetic testing.
  • To evaluate the diagnostic yield of GT in this cohort and its implications for family members.

Main Methods:

  • Retrospective analysis of 257 patients with confirmed DCM or HCM undergoing GT.
  • Data collected from the Essex Inherited Cardiac Conditions Clinic between January 2023 and January 2025.

Main Results:

  • The diagnostic yield of GT was 19.9% for DCM and 17.4% for HCM.
  • 14.8% of gene-positive DCM patients and 14.3% of gene-positive HCM patients did not meet NGTD criteria, often due to age of onset.
  • All DCM patients not meeting criteria showed myocardial fibrosis, suggesting phenotype severity is a key indicator.

Conclusions:

  • Approximately 1 in 7 patients with cardiomyopathy and a pathogenic genotype fall outside current UK testing criteria.
  • Adopting wider ESC guidelines, emphasizing phenotype severity (e.g., myocardial scarring) over strict age cut-offs, is recommended.
  • Implementing broader GT criteria can facilitate predictive testing for an average of 4 at-risk first-degree relatives per identified patient.
Abstract

Related Concept Videos

Testes: Histology01:27

Testes: Histology

A tough, fibrous membrane, the tunica albuginea, covers the testes, extending inward to form fibrous partitions or septa, dividing them into internal compartments called lobules. Each lobule has 1 to 3 tightly coiled seminiferous tubules where sperm production occurs. These tubules merge into a tubular network at the back of the testis, known as the rete testis. It connects to 15 to 20 efferent ductules, leading to the epididymis.
The spermatogenic cells, responsible for producing sperm, are...
2.8K
Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.1K
Testes: Gross Anatomy01:19

Testes: Gross Anatomy

The testes, also known as testicles, are the male gonads. They are housed within the scrotum, a sac-like structure located beneath the penis. The scrotum's primary role is to regulate the temperature of the testes, which is crucial for sperm production.
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
5.7K
Significance Testing: Overview01:04

Significance Testing: Overview

Significance testing is a set of statistical methods used to test whether a claim about a parameter is valid. In analytical chemistry, significance testing is used primarily to determine whether the difference between two values comes from determinate or random errors. The effect of a particular change in the measurement protocol, analyst, or sample itself can cause a deviation from the expected result. In the case of a suspected deviation/outlier, we need to be able to confirm mathematically...
11.6K
Testing Water Quality01:14

Testing Water Quality

When the quality of water for concrete preparation is uncertain, its impact on the setting time of cement and compressive strength of mortar is assessed by comparison with de-ionized or distilled water benchmarks. American Society for Testing and Materials (ASTM) C1602 requires the setting times to be within 90 minutes of the control, British Standard (BS) 3146:1980 allows a 30-minute variance in the initial setting, while British Standards European Norm (BS EN) 1008 specifies initial setting...
378
Types of Hypothesis Testing01:11

Types of Hypothesis Testing

There are three types of hypothesis tests: right-tailed, left-tailed, and two-tailed.
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...
27.8K